https://www.selleckchem.com/products/apd334.html
The patient relapsed three months after transplant and subsequently passed away eleven months after initial diagnosis. Limited literature is available describing this newly identified AML subset. The RAM immunophenotype has been identified as an independent prognostic factor for relapse rate and overall and disease-free survival [1]. Few case reports are available to characterize the genetic profile, typical presentation, and clinical course of patients with this unique immunophenotype.Myeloid sarcoma (MS) is a rare extramedullary blast
Me gusta
Comentario
Compartir
